Company / Total Assets
ANI Pharmaceuticals, Inc. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$1.4B
FY2025
5-year range
$760.1M / $1.4B
FY2021-FY2025
Trend
+12.1%
vs FY2024
Sector context
#56 of 214
Health Care
What the data says
At $1.4B, ANI Pharmaceuticals, Inc.'s total assets ranks #56 of 214 in the Health Care sector. Total Assets has increased for 3 consecutive years, from $760M in FY2022 to $1.4B in FY2025.
Based on SEC 10-K filings.
$1.4B in FY2025 with a 5-year CAGR of +25.6%.
Improved from $904M to $1.4B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +23.7%
- 5-Year CAGR
- +25.6%
- 10-Year CAGR
- -
Sector benchmark
#56 of 214 in Health CareTop 26% of 214This company $1.4B Sector average $7.5B
▼
-80.7% below sector average
Key checks
Key Insights
- ANI Pharmaceuticals, Inc.'s total assets has grown for 3 consecutive years.
- 5-year CAGR of +25.6%, indicating consistent growth.
- In FY2025, total assets increased 12.1% year-over-year.
- Ranks #56 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.4B | +12.1% |
| FY2024 | $1.3B | +42.0% |
| FY2023 | $904.4M | +19.0% |
| FY2022 | $760.1M | -1.5% |
| FY2021 | $771.6M | +67.3% |
| FY2020 | $461.2M | +1.0% |
| FY2019 | $456.8M | +6.1% |
| FY2018 | $430.6M | +4.5% |
| FY2017 | $412.1M | +27.7% |
| FY2016 | $322.9M | +13.2% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026